Skip to main content

Table 4 Direct cost to the providers due to human antibiotic consumption in each resistant infection

From: Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use

  Thailand United States
S. aureus E. coli K. pneumoniae A. baumanii P. aeruginosa S. aureus E. coli K. pneumoniae A. baumanii P. aeruginosa
Total infections 18,725 11,116 15,239 36,553 6118 80,461 10,400 24,900 7300 6700
Cost per infection 1551 956 956 1749 1601 1415 1415 1415 1415 1415
Direct cost (million US$) 29.0 10.6 14.6 63.9 9.8 113.8 14.7 35.2 10.3 9.5
RMf 0.37 0.27 0.35 0.45 0.52 0.37 0.27 0.35 0.45 0.52
Direct cost due to human consumption (million US$) 10.7 2.9 5.1 28.8 5.1 42.1 4.0 12.3 4.6 4.9